Abe K, Yamamoto K, Sinohara H
Department of Biochemistry, Kinki University School of Medicine, Osaka.
J Biochem. 1989 Oct;106(4):564-8. doi: 10.1093/oxfordjournals.jbchem.a122896.
The interactions of mouse murinoglobulin and alpha-macroglobulin with several proteinases were investigated by filtration and by assays of amidolytic activity towards synthetic substrates in the presence of proteinaceous enzyme inhibitors as well as assays of the inhibition of proteolytic activity. Mouse alpha-macroglobulin formed complexes with thrombin, clotting factor Xa, plasmin, pancreatic kallikrein, plasma kallikrein, submaxillary gland trypsin-like proteinase, neutrophil elastase, and pancreatic elastase. These complexes lost the proteolytic activities against high-molecular-weight substrates, but protected the active sites of the enzymes from inactivation by their proteinaceous inhibitors. Mouse murinoglobulin showed essentially the same properties except (i) that it did not form a complex with the clotting factor Xa, and (ii) that it did not protect plasma kallikrein, neutrophil elastase or submaxillary proteinase from inactivation by their proteinaceous inhibitors, although it formed complexes with these proteinases. No interaction was detected between Clostridium histolyticum collagenase and murinoglobulin or alpha-macroglobulin. These results indicate (i) that murinoglobulin has a proteinase-binding spectrum similar to that of alpha-macroglobulin, but is weaker in the ability to protect the bound proteinases from inactivation by the proteinaceous inhibitors than alpha-macroglobulin and (ii) that mouse alpha-macroglobulin has essentially the same inhibitory spectrum as the human homologue.
通过过滤以及在存在蛋白质酶抑制剂的情况下对合成底物的酰胺水解活性测定和蛋白水解活性抑制测定,研究了小鼠的鼠球蛋白和α-巨球蛋白与几种蛋白酶的相互作用。小鼠α-巨球蛋白与凝血酶、凝血因子Xa、纤溶酶、胰激肽释放酶、血浆激肽释放酶、颌下腺类胰蛋白酶、中性粒细胞弹性蛋白酶和胰弹性蛋白酶形成复合物。这些复合物失去了对高分子量底物的蛋白水解活性,但保护了酶的活性位点不被其蛋白质抑制剂灭活。小鼠鼠球蛋白表现出基本相同的特性,只是(i)它不与凝血因子Xa形成复合物,以及(ii)尽管它与这些蛋白酶形成复合物,但它不能保护血浆激肽释放酶、中性粒细胞弹性蛋白酶或颌下蛋白酶不被其蛋白质抑制剂灭活。未检测到溶组织梭菌胶原酶与鼠球蛋白或α-巨球蛋白之间的相互作用。这些结果表明(i)鼠球蛋白具有与α-巨球蛋白相似的蛋白酶结合谱,但在保护结合的蛋白酶不被蛋白质抑制剂灭活方面的能力比α-巨球蛋白弱,以及(ii)小鼠α-巨球蛋白具有与人类同源物基本相同的抑制谱。